Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Genenews Ltd (OTHER OTC: GNWSF)

$0.26 USD -$0.00 (-1.76%)
Last Price $0.2565
Net Change $-0.0046 (-1.76%)
Bid $0
Ask Price $0
Open Price $0.2565
Previous Close Price $0.2611
High Price $0.2565
Low Price $0.2565
Number of Trades 0
Volume 10,800
Fifty Two Week High $0.527 (2016-10-10)
Fifty Two Week Low $0.113 (2016-04-20)
Average Daily Volume 41,738
Share Outstanding 81,650 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-0.02
Last Quarter EPS $
Market Capitalization $0.02B
Insider Shareholders % 0%
Annual Revenue $0B
No. Shares Outstanding 81,650
Inst. Shareholder % 0.01%
Annual Net Income $0B
TTM Net Profit Margin $100.01
1-Year Return 126.99%
3-Year Return -77.5%
5-Year Return -71.11%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 1-6
Beta 7.61
GeneNews Ltd. is a molecular diagnostics company. It focused on the development and application of functional genomics to enable early diagnosis and personalized health management based on disease specific biomarkers. The company's patented core platform technology consists of the Sentinel Principle(R) which detects and stages virtually any disease or medical condition from a simple blood sample. It applies the Sentinel Principle in the areas of cancer, arthritis, cardiovascular diseases and neurological disorders. The company's lead product includes ColonSentry(R), a blood-based molecular test to pre-screen and assess an individual's risk of having colorectal cancer. GeneNews Ltd. is headquartered in Richmond Hill, Canada.

GNWSF News & Stock Updates